Company Filing History:
1 out of 131,611 
1 out of 8 Years Active: 2017
Title: Yumi Lee: Innovator in Combination Therapy
Introduction
Yumi Lee is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of medicine, particularly in the area of combination therapies for treating diseases related to c-Met and EGFR.
Latest Patents
Yumi Lee holds a patent for a method of combination therapy using an EGFR antagonist and an anti-c-Met antibody. This innovative approach provides a method for the prevention and treatment of diseases induced by c-Met and/or EGFR. The patent outlines the co-administration of a pharmaceutically effective amount of both an EGFR antagonist and an anti-c-Met antibody to subjects in need.
Career Highlights
Throughout her career, Yumi Lee has worked with notable companies, including Samsung Electronics Co., Ltd. and Samsung Life Welfare Foundation. Her experience in these organizations has allowed her to develop her expertise in medical innovations.
Collaborations
Yumi has collaborated with talented individuals such as Saet Byoul Lee and Jae Young Choi, contributing to her success in the field.
Conclusion
Yumi Lee's work in combination therapy represents a significant advancement in the treatment of c-Met and EGFR-induced diseases. Her innovative approach and dedication to research continue to impact the medical community positively.